PAF-antagonistic thienotriazolodiazepine compounds and pharmaceutical uses thereof
申请人:Yoshitomi Pharmaceutical Industries, Ltd.
公开号:EP0268242A1
公开(公告)日:1988-05-25
A thienotriazolodiazepine compound of the general formula (I):
wherein each symbol is as defined in the specification and a pharmaceutically acceptable acid addition salt thereof, and pharmaceutical uses thereof.
Said compounds exhibit PAF-antagonistic activity and are useful for the prevention or treatment of various PAF-induced diseases.
通式(I)的噻吩三唑二氮杂卓化合物:
其中各符号如说明书中所定义及其药学上可接受的酸加成盐,以及它们的药物用途。
所述化合物具有 PAF 拮抗活性,可用于预防或治疗各种 PAF 引起的疾病。